Cloopen Group Holding Limited Sponsored ADR RAAS
1.13
0.00
0.00%
as of 11 Jun
- Market cap
- $121.2M
- P/E
- 0.0×
Follow RAAS
| Dec '21 | Sep '21 | Jun '21 | Mar '21 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 |
+3 more quarters Free account |
P/S ratio |
1.21 | 1.63 | 3.31 | 0.00 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(3.81) | (26.62) | (48.74) | (52.61) | |
P/B ratio |
0.39 | 0.54 | 1.07 | 1.17 | |
Price to Tangible BV |
0.43 | 0.58 | 1.14 | 1.25 | |
EV/Sales |
(1.96) | (0.67) | 0.71 | 0.00 | |
EV/EBITDA |
1.62 | 6.51 | 0.00 | 0.00 | |
EV/Operating CF |
2.40 | 0.00 | 0.00 | 0.00 | |
EV/FCF |
2.32 | 0.00 | 0.00 | 0.00 | |
Quick Ratio |
3.64 | 6.77 | 4.69 | 4.80 | |
Current Ratio |
3.87 | 7.22 | 4.98 | 5.08 | |
Net Debt/EBITDA |
4.30 | 22.42 | 25.48 | 18.45 | |
Debt/Assets |
0.45% | 0.00% | 6.55% | 0.58% | |
Debt/Equity |
0.01 | 0.00 | 0.08 | 0.01 | |
Asset Turnover |
0.38 | 0.50 | 0.44 | — | |
Operating CF/Net income |
0.08 | 0.00 | 0.00 | 0.00 | |
Capex/Depreciation |
(0.82) | — | — | — | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
917.73% | 27.36% | 22.63% | 33.58% | |
Selling, General and Administrative Expense of Revenue |
2,034.59% | 58.76% | 55.68% | 82.76% | |
Intangible Assets out of Total Assets |
0.06 | 0.06 | 0.05 | 0.05 | |
Share Based Compensation of Revenue |
2,690.80% | 0.00% | 0.00% | 0.00% | |
Graham Net Nets |
2.19 | 1.66 | 0.85 | 0.77 | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(1,618.07%) | (1,061.63%) | (551.46%) | (100.95%) | |
Free Cash Flow Yield |
(69.91%) | 0.00% | 0.00% | 0.00% | |
Revenue per Share |
0.03 | 0.74 | 0.77 | 0.85 | |
Operating CF per Share |
(0.76) | 0.00 | 0.00 | 0.00 | |
Capex per Share |
(0.03) | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(0.79) | 0.00 | 0.00 | 0.00 | |
Cash per Share |
7.65 | 7.10 | 7.56 | 11.60 | |
Shareholders Equity per Share |
7.36 | 8.15 | 7.95 | 11.69 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
7.36 | 8.15 | 7.95 | 11.69 | |
Free Cash Flow |
(38.71) | — | — | — | |
Working Capital |
315.46 | 428.52 | 402.27 | 392.43 | |
Capital Expenditures |
(1.35) | — | — | — | |
Net Current Asset Value |
312.29 | 424.29 | 397.63 | 387.36 | |
EV/EBIT |
1.62 | 6.37 | 0.00 | 0.00 | |
Capex to Sales |
0.84 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
(27,437.92%) | (40.38%) | (38.93%) | (1,375.41%) | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
31.22 | 45.98 | 45.18 | — | |
Average Payables |
21.70 | 23.11 | 22.37 | — | |
Average Assets |
311.65 | 310.41 | 320.89 | — | |
Average Common Equity |
(179.55) | 119.54 | 126.70 | — |
Columns are period end dates